These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15054402)

  • 21. Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation.
    Mohammad-Qureshi SS; Jennings MD; Pavitt GD
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):658-64. PubMed ID: 18631136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. eIF2B, a mediator of general and gene-specific translational control.
    Pavitt GD
    Biochem Soc Trans; 2005 Dec; 33(Pt 6):1487-92. PubMed ID: 16246152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. eIF2B-related disorders: antenatal onset and involvement of multiple organs.
    van der Knaap MS; van Berkel CG; Herms J; van Coster R; Baethmann M; Naidu S; Boltshauser E; Willemsen MA; Plecko B; Hoffmann GF; Proud CG; Scheper GC; Pronk JC
    Am J Hum Genet; 2003 Nov; 73(5):1199-207. PubMed ID: 14566705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary leukodystrophies without identified mutations.
    Robitaille Y
    J Neurol Sci; 2005 Feb; 228(2):208-9. PubMed ID: 15694209
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel mutation in EIF2B gene in a case of adult-onset leukoencephalopathy with vanishing white matter.
    Matsui M; Mizutani K; Ohtake H; Miki Y; Ishizu K; Fukuyama H; Shimohata T; Onodera O; Nishizawa M; Takayama Y; Shibasaki H
    Eur Neurol; 2007; 57(1):57-8. PubMed ID: 17119336
    [No Abstract]   [Full Text] [Related]  

  • 26. The latest on leukodystrophies.
    Schiffmann R; van der Knaap MS
    Curr Opin Neurol; 2004 Apr; 17(2):187-92. PubMed ID: 15021247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients.
    Kantor L; Harding HP; Ron D; Schiffmann R; Kaneski CR; Kimball SR; Elroy-Stein O
    Hum Genet; 2005 Oct; 118(1):99-106. PubMed ID: 16041584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of protein synthesis in lymphoblasts from vanishing white matter patients.
    van Kollenburg B; Thomas AA; Vermeulen G; Bertrand GA; van Berkel CG; Pronk JC; Proud CG; van der Knaap MS; Scheper GC
    Neurobiol Dis; 2006 Mar; 21(3):496-504. PubMed ID: 16185887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients.
    Horzinski L; Kantor L; Huyghe A; Schiffmann R; Elroy-Stein O; Boespflug-Tanguy O; Fogli A
    BMC Neurol; 2010 Oct; 10():94. PubMed ID: 20958979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reconstitution and purification of eukaryotic initiation factor 2B (eIF2B) expressed in Sf21 insect cells.
    Fabian JR; Kimball SR; Jefferson LS
    Protein Expr Purif; 1998 Jun; 13(1):16-22. PubMed ID: 9631509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor.
    Peter L; Niel F; Catenoix H; Jung J; Demarquay G; Petiot P; Rudigoz RC; Boespflug-Tanguy O; Ryvlin P; Mauguière F
    Eur J Neurol; 2008 Jan; 15(1):94-7. PubMed ID: 18005052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF N-glycan profiles to investigate biomarkers in brain developmental disorders: application to leukodystrophies related to eIF2B mutations.
    Fogli A; Merle C; Roussel V; Schiffmann R; Ughetto S; Theisen M; Boespflug-Tanguy O
    PLoS One; 2012; 7(8):e42688. PubMed ID: 22952606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental splicing deregulation in leukodystrophies related to EIF2B mutations.
    Huyghe A; Horzinski L; Hénaut A; Gaillard M; Bertini E; Schiffmann R; Rodriguez D; Dantal Y; Boespflug-Tanguy O; Fogli A
    PLoS One; 2012; 7(6):e38264. PubMed ID: 22737209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Leukoencephalopathy with vanishing white matter: A case report].
    San Antonio-Arce V; Martín Fernández-Mayoralas D; Muñoz-Jareño N; Fresneda-Machado C; Sáiz-Ayala A; Campos-Castelló J
    Rev Neurol; 2006 Nov 1-15; 43(9):535-40. PubMed ID: 17072809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From gene to disease; a defect in the regulation of protein production leading to vanishing white matter].
    Pronk JC; Leegwater PA; van der Knaap MS
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1933-6. PubMed ID: 12404908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways.
    Li W; Wang X; Van Der Knaap MS; Proud CG
    Mol Cell Biol; 2004 Apr; 24(8):3295-306. PubMed ID: 15060152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation. First Polish cases.
    Mierzewska H; van der Knaap MS; Scheper GC; Jurkiewicz E; Schmidt-Sidor B; Szymańska K
    Folia Neuropathol; 2006; 44(2):144-8. PubMed ID: 16823698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes.
    Liu R; van der Lei HD; Wang X; Wortham NC; Tang H; van Berkel CG; Mufunde TA; Huang W; van der Knaap MS; Scheper GC; Proud CG
    Hum Mutat; 2011 Sep; 32(9):1036-45. PubMed ID: 21560189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesis.
    Schiffmann R; Elroy-Stein O
    Mol Genet Metab; 2006 May; 88(1):7-15. PubMed ID: 16378743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.
    Woody AL; Hsieh DT; McIver HK; Thomas LP; Rohena L
    Am J Med Genet A; 2015 Apr; 167A(4):826-30. PubMed ID: 25758335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.